This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| ANGLO AMERICAN PLC | 3,976.0 | 4.6% |
| SHELL PLC | 2,111.5 | 4.4% |
| GLENCORE PLC | 500.7 | 4.2% |
| FRESNILLO PLC | 744.4 | 4.1% |
| RIO TINTO PLC | 6,076.0 | 4.0% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| PEARSON PLC | 739.2 | -5.9% |
| JD SPORTS FASHION PLC | 152.9 | -4.7% |
| DS SMITH PLC | 326.8 | -4.4% |
| ASHTEAD GROUP PLC | 4845.0 | -4.2% |
| ST JAMES’S PLACE PLC | 1457.0 | -4.0% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,579 | 0.6% | 11.9% |
| DOW JONES INDUS. AVG | 35,229 | -0.2% | 6.5% |
| DAX INDEX | 14,606 | -1.5% | -2.7% |
| NIKKEI 225 | 28,027 | -0.8% | -4.0% |
| S&P/ASX 200 INDEX | 7,515 | 0.7% | 10.7% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 107.82 | 3.43% |
| Brent Crude (ICE) | USD/bbl. | 112.76 | 2.30% |
| Gold Spot | USD/t oz. | 1,933 | 0.0% |
| Copper (Comex) | USd/lb. | 475 | 0.4% |
Click graph to enlarge
The UK 100 is called to open -25 points at 7553. The UK’s blue-chip index looks set for a mixed start as oil prices dropped overnight on reports the US is set for the largest release from its strategic reserve since its creation in 1974. US President Joe Biden is poised to authorise the release of up to 180 million barrels of oil, according to the reports. In Asia, China's official manufacturing PMI fell to 49.5 in March from 50.2 a month ago, indicating an economy in decline with services also contracting. Covid lockdowns were blamed for the dip, which should be reversed next month predicted economists. Overnight U.S. stocks slid on Wednesday, ending a winning streak for the market, The S&P fell 0.63% to 4,602.45, and Nasdaq lost 1.21% to 14,442.27. The Dow Jones dropped 65.38 points, or 0.19%, to 35,228.81. The Dow and S&P each snapped a four-day stretch of gains.
GlaxoSmithKline's Viv Healthcare wins US FDA approval for Triumeq PD tablets to treat HIV.
James Halstead reports a 2021 pretax profit of £25.4m (2020: £26m profit) as they state the decline in profit YoY is due to higher raw material and energy costs.
Provident Financial swings to a FY pretax profit of £4.1m (2020: £133.5m loss). They declare an interim dividend of 12p per share as they state improvement in profitability driven by favourable backdrop. There has been "encouraging momentum" in first two months of 2022.
Tate & Lyle are to buy prebiotic dietary fibre business Quantum for $237m.
Tate & Lyle are to buy prebiotic dietary fibre business Quantum for $237m.
Exane BNP Downgrades Vodafone to Underperform (14 Buys / 1 Hold / 0 Sells)
Jefferies Downgrades Hargreaves Lansdown to Underperform from Hold (5 Buys / 5 Holds / 3 Sells)
JP Morgan Upgrades M&G to Neutral from Underweight (4 Buys / 4 Holds / 0 Sells)
Ultra Electronics - Estimated date not confirmed
None
Chinese NBS Manufacturing PMI
UK Gross Domestic Product
German Retail Sales
German Unemployment Rate
OPEC Meeting
EU Unemployment Rate
US Initial Jobless Claims
Fed's Williams speech
Tankan Large Manufacturing Index
FTSE 100:
Phoenix Group Holdings
Taylor Wimpey
Smith & Nephew
InterContinental Hotels Group
FTSE 250:
Hammerson
Moneysupermarket.com Group
Travis Perkins
ContourGlobal
ConvaTec Group
Fidelity European Trust
Mercantile Investment Trust
Primary Health Properties
Finsbury Growth & Income Trust
Games Workshop Group
RIT Capital Partners
Hammerson
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.